What it does
Cyromazine is a medication used to treat certain conditions related to pests in veterinary medicine.
Commonly used for: pest control in animals
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.
Sourcing - Kenya onlyRegistration & product details
Source: Zambia Medicines Regulatory Authority · fetched 2026-03-12 00:03:17 · updated 2026-10-22 03:35:16
About this medicine
Cyromazine is a medication used to treat certain conditions related to pests in veterinary medicine.
What it treats
- pest control in animals
How it works
Cyromazine works by affecting the growth and development of insects, preventing them from maturing into adults.
Who it's for
This medication is generally used in veterinary practices for animals that are affected by pest infestations.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: cyromazine
BNF-referencedCyromazine is an insect growth regulator that primarily functions as an insecticide, particularly effective against dipteran insects. It works by disrupting normal insect growth and development, specifically affecting moulting and pupation processes. Cyromazine acts systemically when applied to plants, making it useful in agricultural pest control.
Indications
- Control of dipteran insects in agricultural settings
Dosage
Children: Refer to the BNF for Children for paediatric dosing recommendations.
Adults: Refer to specific guidelines in the BNF for appropriate dosing information.
Mechanism of action
Cyromazine is an insect growth regulator with contact action, which interferes with moulting and pupation. Its exact mode of action is not fully understood; however, it is believed to interfere with the hormone system, sclerotization of the cuticle, or nucleic acid metabolism. Research has indicated that it may inhibit the function of a gene (CG32743) that is involved in phosphatidylinositol kinase-like kinase activity, which is important in cellular processes, including responses to DNA damage.
Pharmacodynamics
Cyromazine affects the growth and development of insects, leading to disruption in their life cycle. The insecticidal activity is primarily due to its interference with moulting and pupation. This results in the inability of insects to progress through their developmental stages, ultimately leading to their death.
Pharmacokinetics
Cyromazine demonstrates systemic action when applied to plants, suggesting it is absorbed and translocated within plant tissues. Specific pharmacokinetic data in mammals or detailed absorption, distribution, metabolism, and excretion profiles are not well-documented in the available literature.
Pregnancy
Cyromazine should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. Consult a healthcare professional for guidance.
Breast-feeding
It is not known whether cyromazine is excreted in human milk. Caution should be exercised when administering to nursing mothers.
Storage
Store in a cool, dry place away from direct sunlight and out of reach of children.
Formulations
- Insecticide formulations containing cyromazine for agricultural use
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Molecular reference: cyromazine
PubChem CID 47866Molecular formula: C6H10N6
Mechanism of action
Insect growth regulator with contact action, which interferes with moulting and pupation. When used on plants, action is systemic. Cyromazine is an effective insecticide used to control dipteran insects. Its precise mode of action is yet to be determined, although it has been suggested that it interferes with the hormone system, sclerotization of the cuticle, or nucleic acid metabolism. To understand the way in which cyromazine acts, /the authors/ positionally cloned a cyromazine resistance gene from Drosophila melanogaster. Six cyromazine resistance alleles had previously been generated by ethyl methanasulfonate treatment. Two of these failed to complement each other and here /the authors/ identify them as having independent non-sense mutations in CG32743, which is an ortholog of Smg1 of worms and mammals and encodes a phosphatidylinositol kinase-like kinase (PIKK). RNAi experiments confirm that cyromazine resistance can be achieved by knocking down CG32743. These are the first cyromazine resistant mutations identified at the nucleotide level. In mammals Smg1 phosphorylates P53 in response to DNA damage. This finding supports the hypothesis that cyromazine interferes with nucleic acid metabolism.
Biological pathways
Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.